| Date | Time | Source | Headline | Symbol | Company |
| 10/03/2019 | 5:04PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 09/24/2019 | 6:00AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 09/23/2019 | 5:10PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 09/23/2019 | 5:06PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 09/13/2019 | 5:19PM | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 08/27/2019 | 10:03AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 08/16/2019 | 5:02PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 08/14/2019 | 5:12PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 08/14/2019 | 4:16PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/23/2019 | 9:59AM | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/23/2019 | 9:58AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/22/2019 | 5:21PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/18/2019 | 2:12PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/17/2019 | 5:27PM | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/16/2019 | 4:01PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/12/2019 | 5:24PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/11/2019 | 5:30PM | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/11/2019 | 5:28PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/10/2019 | 5:21PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/10/2019 | 5:19PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/08/2019 | 5:26PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/03/2019 | 4:06PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/03/2019 | 4:05PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/03/2019 | 10:00AM | GlobeNewswire Inc. | Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019 | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/02/2019 | 5:04PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 06/07/2019 | 10:28AM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 06/07/2019 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 06/06/2019 | 5:16PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 06/03/2019 | 5:22PM | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 05/22/2019 | 5:17PM | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |